XML 21 R8.htm IDEA: XBRL DOCUMENT v3.7.0.1
Consolidated Statements Of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Operating Activities    
Net income $ 16,026 $ 11,702
Adjustments to reconcile net income to net cash provided by operating activities:    
Accretion and amortization 361 117
Provision for loan losses 681 539
Depreciation 1,525 1,567
Deferred income tax expense 2,931 830
Net periodic employee benefit cost 114 129
Realized investment securities gains 4,276 0
Stock-compensation expense 780 755
Excess tax benefit from stock-compensation expense (189) 0
Proceeds from bank-owned life insurance 1,137 0
Increase in value of bank-owned life insurance (749) (760)
Loans originated for sale (3,951) (2,809)
Proceeds from the sale of loans originated for sale 6,118 3,107
Gain on sale of loans (167) (58)
Change in accrued interest receivable (236) (1,085)
Change in other assets (131) (10,630)
Change in other liabilities 383 11,432
Net Cash Provided by Operating Activities 20,357 14,836
Investing Activities    
Proceeds from sales of securities available-for-sale 5,576 35
Proceeds from maturities and calls of securities available-for-sale 23,390 18,078
Proceeds from maturities and calls of securities held-to-maturity 2,823 2,332
Purchases of securities available-for-sale (39,747) (4,289)
Net increase in loans (30,826) (14,668)
Purchases of premises and equipment (2,111) (610)
Disposals of premises and equipment 1,781 341
Net Cash (Used in) Provided by Investing Activities (39,114) 1,219
Financing Activities    
Net increase in non-interest-bearing deposits 42,505 45,450
Net increase in interest-bearing deposits 118,616 57,994
Net (decrease) increase in short-term borrowings (61,619) 1,845
Proceeds from issuance of common stock 28,408 0
Purchases of treasury stock 0 (9,925)
Proceeds from stock option exercises 38 0
Proceeds from exercise of stock options   0
Dividends paid (6,518) (6,367)
Net Cash Provided by Financing Activities 121,430 88,997
Increase in Cash and Cash Equivalents 102,673 105,052
Cash and cash equivalents at beginning of period 88,139 70,113
Cash and Cash Equivalents at End of Period $ 190,812 $ 175,165